FEBRUARY 20, 2012

Browse Categories

AUA 2008 - Phase 1 Study of Multi-Dose Administration of Intravesical CG0070 in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)

Fri, 23 May 2008  |  David P. Wood, MD
E-mail Print

ORLANDO, FL (UroToday.com) - CG0070 is a replication-competent adenovirus modified to replicate preferentially in retinoblastoma pathway-defective cancers and to express granulocyte-macrophage colony-stimulating factor (GM-CSF).




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |